Literature DB >> 32086647

Interventional treatment of tricuspid regurgitation : An important innovation in cardiology.

Georg Goliasch1, Julia Mascherbauer2.   

Abstract

Entities:  

Year:  2020        PMID： 32086647     DOI： 10.1007/s00508-020-01621-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  14 in total

1.  Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler Assessment.

Authors:  Philipp E Bartko; Henrike Arfsten; Maria K Frey; Gregor Heitzinger; Noemi Pavo; Anna Cho; Stephanie Neuhold; Timothy C Tan; Guido Strunk; Christian Hengstenberg; Martin Hülsmann; Georg Goliasch
Journal:  JACC Cardiovasc Imaging       Date:  2019-01-16

Review 2.  Tricuspid regurgitation is a public health crisis.

Authors:  Maurice Enriquez-Sarano; David Messika-Zeitoun; Yan Topilsky; Christophe Tribouilloy; Giovanni Benfari; Hector Michelena
Journal:  Prog Cardiovasc Dis       Date:  2019-11-09       Impact factor: 8.194

3.  Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.

Authors:  Georg Nickenig; Marcel Weber; Philipp Lurz; Ralph Stephan von Bardeleben; Marta Sitges; Paul Sorajja; Jörg Hausleiter; Paolo Denti; Jean-Noël Trochu; Michael Näbauer; Abdellaziz Dahou; Rebecca T Hahn
Journal:  Lancet       Date:  2019-11-07       Impact factor: 79.321

Review 4.  Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.

Authors:  Hans R Figulla; Katharina Kiss; Alexander Lauten
Journal:  EuroIntervention       Date:  2016-09-18       Impact factor: 6.534

5.  Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.

Authors:  Nelson Wang; Jordan Fulcher; Nishan Abeysuriya; Michele McGrady; Ian Wilcox; David Celermajer; Sean Lal
Journal:  Eur Heart J       Date:  2019-02-01       Impact factor: 29.983

6.  Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study.

Authors:  Stephanie Neuhold; Martin Huelsmann; Elisabeth Pernicka; Alexandra Graf; Diana Bonderman; Christopher Adlbrecht; Thomas Binder; Gerald Maurer; Richard Pacher; Julia Mascherbauer
Journal:  Eur Heart J       Date:  2013-01-18       Impact factor: 29.983

7.  A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.

Authors:  Gerd Hasenfuß; Chris Hayward; Dan Burkhoff; Frank E Silvestry; Scott McKenzie; Finn Gustafsson; Filip Malek; Jan Van der Heyden; Irene Lang; Mark C Petrie; John G F Cleland; Martin Leon; David M Kaye
Journal:  Lancet       Date:  2016-03-26       Impact factor: 79.321

8.  Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.

Authors:  Andrea L Axtell; Vijeta Bhambhani; Philicia Moonsamy; Emma W Healy; Michael H Picard; Thoralf M Sundt; Jason H Wasfy
Journal:  J Am Coll Cardiol       Date:  2019-05-06       Impact factor: 24.094

9.  Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.

Authors:  Julia Mascherbauer; Andreas A Kammerlander; Caroline Zotter-Tufaro; Stefan Aschauer; Franz Duca; Daniel Dalos; Susanne Winkler; Matthias Schneider; Jutta Bergler-Klein; Diana Bonderman
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 10.  Advances in transcatheter mitral and tricuspid therapies.

Authors:  Pavel Overtchouk; Nicolo Piazza; Juan Granada; Osama Soliman; Bernard Prendergast; Thomas Modine
Journal:  BMC Cardiovasc Disord       Date:  2020-01-07       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.